Sanofi partners with Synthekine in immunology race

Synthekine is teaming up with Sanofi in a $40 million-plus collaboration to develop IL-10 receptor agonists for autoimmune and inflammatory diseases.

The cytokine-focused biotech will receive the $40 million upfront with the potential for undisclosed additional preclinical, development, regulatory and commercial milestones, as well as tiered royalties on net sales….
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks